ESC 365 - Antiarrythmia Device use in Myotonic Dystrophy population: A Single Center Experience

EHRA Premium Access

Antiarrythmia Device use in Myotonic Dystrophy population: A Single Center Experience

Session: Arrhythmias general - The unusual and unexpected

Topic: Device Treatment of Ventricular Arrhythmias and SCD

Speaker: Mr N. Gruner-Hegge (Cambridge, GB)

Event: EHRA 2018

Congress Presentation

About the speaker

Mr Nicolai Gruner-Hegge

Cambridge (United Kingdom of Great Britain & Northern Ireland)

0 follower

8 more presentations in this session

Aetiologies of atrioventricular block in patients younger than 50 years at time of first pacemaker implantation - A nationwide Danish study

Speaker: Doctor J. Rudbeck-Resdal (Aarhus, DK)

Metabolically healthy obesity and risk for atrial fibrillation

Speaker: Mrs T. Feng (Trondheim, NO)

Particulate matter air pollution and incident atrial fibrillation in a general healthy population: a nationwide cohort study

Speaker: Doctor I. Kim (Seoul, KR)

Impact of persistent ST elevation on outcome in patients with Takotsubo syndrome. Results from the GErman Italian STress Cardiomyopathy (GEIST) registry.

Speaker: Doctor F. Santoro (Foggia, IT)

Idiopathic atrial fibrillation as an inflammatory condition

Speaker: Mr R. Batalov (Tomsk, RU)

Access the full session

Arrhythmias general - The unusual and unexpected

Speakers: Mr N. Gruner-Hegge, Doctor J. Rudbeck-Resdal, Mrs T. Feng, Doctor I. Kim, Doctor F. Santoro...

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

Related content

ESC Premium Access

Postcovid myocarditis diagnosed by endomyocardial biopsy and/or magnetic resonance imaging 2-9 months after acute COVID-19

27 August 2021

ESC Premium Access

Arrhythmic mitral valve prolapse and mitral annular disjunction.

27 August 2021

ESC Premium Access

Acute and chronic myocardial injury in patients with COVID-19

27 August 2021

ESC 365 is supported by